Big Data may likely change the landscape of complex diagnostics, but regulatory barriers and traditional thinking is holding it back. Do we need to change?, ask professors Stephen R. Master and Viktor Mayer-Schönberger in their recent opinion piece in “Clinical Chemistry”.